Background: Hematopoietic stem cell transplantation (HSCT) remains the only definitive treatment for many benign and malignant hematologic disorders. Despite advances in transplant medicine, HSCT still carries a significant risk of serious complications, including idiopathic pneumonia syndrome (IPS). IPS is characterized by diffuse alveolar injury that is not due to infection or fluid overload. IPS affects […]